Related Experiment Video
Updated: Jul 14, 2026
05:36
Herbs-Partitioned Moxibustion on the Navel in a Rat Model of Primary Dysmenorrhea with Cold Coagulation and Blood Stasis
Published on: October 4, 2024
Passive smoking, Cyp1A1 gene polymorphism and dysmenorrhea
Hong Liu1, Fan Yang, Zhiping Li
1Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, China.
Reproductive Toxicology (Elmsford, N.Y.)
|June 15, 2007
Summary
Passive smoking increases dysmenorrhea risk, especially in women with specific CYP1A1 gene variants (MspI and HincII). These genetic factors significantly modify the association between secondhand smoke exposure and menstrual pain.
Area of Science:
- Environmental Health
- Genetics
- Reproductive Health
Background:
- Passive smoking is a potential risk factor for various health issues.
- Dysmenorrhea, or painful menstruation, affects a significant portion of women.
- Genetic susceptibility may play a role in the health effects of environmental exposures.
Purpose of the Study:
- To investigate if CYP1A1 MspI and CYP1A1 HincII gene polymorphisms modify the association between passive smoking and dysmenorrhea.
- To assess the combined effect of passive smoking exposure and specific genetic variants on dysmenorrhea risk.
Main Methods:
- A study of 1645 non-smoking, non-drinking newlywed female workers in China.
- Logistic regression models were used to analyze associations between passive smoking, genetic susceptibility (CYP1A1 MspI and HincII genotypes), and dysmenorrhea, adjusting for stress.
- Genotyping was performed to identify specific alleles.
Main Results:
- Passive smoking was associated with an increased odds ratio (OR) for dysmenorrhea in women with specific genotypes (Ile/Ile462 and C/C6235).
- A significant combined effect was observed between passive smoking and the CYP1A1 MspI C/C6235 and HincII Ile/Ile462 genotypes (OR=2.6).
Conclusions:
- CYP1A1 MspI and HincII genotypes significantly modify the association between passive smoking exposure and dysmenorrhea.
- Genetic predisposition influences the impact of secondhand smoke on menstrual pain.
Related Concept Videos
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:28Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...